aprindine has been researched along with Myocardial Ischemia in 1 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takase, B | 1 |
| Uehata, A | 1 |
| Nishioka, T | 1 |
| Arakawa, K | 1 |
| Satomura, K | 1 |
| Ohsuzu, F | 1 |
| Kurita, A | 1 |
1 trial available for aprindine and Myocardial Ischemia
| Article | Year |
|---|---|
Effect of aprindine on heart rate variability indices in patients with ischemic heart disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Aprindine; Circadian Rhythm; Coronary Angiog | 1999 |